Dr Reddys Laboratories Q2 Results

  • BSE: 500124
  • NSE: DRREDDY
  • ISIN: INE089A01023
  • Sector: Biotechnology & Drugs
BSE
6,097.789.00 (1.48%)
Volume4.46 K
Updated: Mon 24 Jun, 2024 | 15:29:04
NSE
6,054.9543.50 (0.72%)
Volume3.25 L
Updated: Mon 24 Jun, 2024 | 15:40:00
Today: 5,958.05
6,097.70
52-Wk: 4,864.25
6,505.50

Q2 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Dr Reddys Laboratories Q2 Results

    *All figures in crores except per share values
    Fiscal PeriodSep 23Jun 23QoQ Comp
    Total Revenue 6,902.606,757.902.14%
    Selling/ General/ Admin Expenses Total 2,885.802,757.104.67%
    Depreciation/ Amortization 375.50353.306.28%
    Total Operating Expense 5,171.404,995.103.53%
    Operating Income 1,731.201,762.80-1.79%
    Net Income Before Taxes 1,916.701,850.003.61%
    Net Income 1,482.201,405.005.49%
    Diluted Normalized EPS 84.6081.953.24%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanGet App